Completion lymphadenectomy for sentinel node positive cutaneous head & neck melanoma

The application and utility of melanoma sentinel lymph node biopsy (SLNB) has evolved significantly since its inception over two decades ago. The current focus has shifted from a staging modality to potentially a therapeutic intervention. Recent research to include large multi‐institutional randomized trials have attempted to answer the question: is a completion lymph node dissection (CLND) required following a positive SLNB? This review provides an evidence‐based, contemporary review of the utility of CLND for SLNB positive head and neck cutaneous melanoma patients.Level of EvidenceNAPeer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/142560/1/lio2136.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/142560/2/lio2136_am.pd